1 | Levodopa Benserazide Madopar | 2件: Benserazide Benserazide, Levodopa | 2件: D00059
D00059
,
D03082
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
2 | Madopar | - | - | - | - | 1件: 6 6 |
3 | Madopar 125 mg T, tablets | - | - | - | - | 1件: 6 6 |
4 | Madopar 125 mg, orodispersible tablet | - | - | - | - | 1件: 6 6 |
5 | Madopar 200+50 mg | - | - | - | - | 1件: 6 6 |
6 | Madopar LT | - | - | - | - | 1件: 6 6 |
7 | Madopar monotherapy | - | - | - | - | 1件: 6 6 |
8 | Madopar Tab. 125 or Perkin Tab. 25-100mg | - | - | - | - | 1件: 6 6 |
9 | Madopar® 125 | - | - | - | - | 1件: 6 6 |
10 | Madopar® 125 mg T Tablets Levodopa 100 mg Benserazide 25 mg (as benserazide hydrochloride) | 2件: Benserazide Benserazide, Levodopa | 2件: D00059
D00059
,
D03082
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
11 | Madopar® 250 | - | - | - | - | 1件: 6 6 |
12 | Madopar® HBS | - | - | - | - | 1件: 6 6 |
13 | Madopar® HBS 125 | - | - | - | - | 1件: 6 6 |